March 24, 2026 a 01:00 pm
ZTS: Fundamental Ratio Analysis - Zoetis Inc.
Zoetis Inc., a leader in animal health, focuses on discovering and developing innovative veterinary medicines and vaccines. With a robust portfolio serving both livestock and companion animals, Zoetis demonstrates a strong commitment to innovation and growth in the healthcare sector.
Fundamental Rating
The fundamental ratings for Zoetis Inc. indicate solid performance, particularly with high returns on equity and assets, though there is room for improvement in debt management.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 1 |
Historical Rating
This section provides insights into the stability and changes in the company's financial health over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-23 | 3 | 4 | 5 | 5 | 1 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 1 | 2 | 1 |
Analyst Price Targets
Analysts remain optimistic about Zoetis' future, with median price targets suggesting potential growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| $160 | $135 | $140 | $143.86 |
Analyst Sentiment
The analyst sentiment reflects a balance between conservative and moderately optimistic views, with a consensus leaning towards 'Hold'.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 14 | |
| Hold | 15 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Zoetis Inc. continues to demonstrate strong financial health, with substantial growth potential as indicated by analyst price targets. However, ongoing debt management and valuation challenges may temper expectations. The company's innovation-driven approach in animal health places it well for long-term stability and growth, though investors should consider market conditions and potential risks in the sector. Overall, the mixed analyst ratings suggest a cautious yet optimistic outlook for investors considering the stock.